Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study

被引：2

作者：

Visentin, Andrea ^{[1
,2
]}

Mauro, Francesca Romana ^{[3
]}

Scarfo, Lydia ^{[4
,5
]}

Gentile, Massimo ^{[6
,7
]}

Farina, Lucia ^{[8
]}

Reda, Gianluigi ^{[9
]}

Ferrarini, Isacco ^{[10
]}

Proietti, Giulia ^{[3
]}

Derenzini, Enrico ^{[11
]}

Cibien, Francesca ^{[12
]}

Vitale, Candida ^{[13
,14
]}

Sanna, Alessandro ^{[15
]}

Pietrasanta, Daniela ^{[16
]}

Marchetti, Monia ^{[16
]}

Murru, Roberta ^{[17
]}

Rigolin, Gian Matteo ^{[18
]}

Sportoletti, Paolo ^{[19
,20
,21
]}

Trimarco, Valentina ^{[1
]}

Cavarretta, Chiara Adele ^{[1
]}

Angotzi, Francesco ^{[1
]}

Cellini, Alessandro ^{[1
]}

Ruocco, Valeria ^{[1
]}

Zatta, Ivan ^{[1
]}

Laurenti, Luca ^{[22
]}

Molica, Stefano ^{[23
]}

Coscia, Marta ^{[13
,14
]}

Ghia, Paolo ^{[4
,5
]}

Foa, Robin ^{[3
]}

Cuneo, Antonio ^{[18
]}

Trentin, Livio ^{[1
,2
,24
]}

机构：

[1] Univ Padua, Dept Med, Hematol & Clin Immunol Unit, Padua, Italy

[2] Veneto Inst Mol Med, Padua, Italy

[3] Sapienza Univ, Dept Translat & Precis Med, Hematol, Rome, Italy

[4] Univ Vita Salute San Raffaele, Strateg Res Program CLL, Milan, Italy

[5] IRCCS Osped San Raffaele, Milan, Italy

[6] Azienda Osped Cosenza, Hematol Unit, Cosenza, Italy

[7] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy

[8] Fdn IRCCS Ist Nazl Tumori, Div Hematol, Milan, Italy

[9] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore, Hematol Unit, Milan, Italy

[10] Univ Verona, Dept Engn Innovat Med, Sect Hematol, Verona, Italy

[11] European Inst Oncol IRCCS, Haematol Programme, Div Haematooncol, Milan, Italy

[12] Ca Foncello Hosp, Hematol Unit, Treviso, Italy

[13] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy

[14] AOU Citta Salutee Sci Torino, Div Hematol, Turin, Italy

[15] AOU Careggi, Dept Oncol, Hematol Unit, Florence, Italy

[16] AO SS Antonio & Biagio & Cesare Arrigo, Div Hematol, Alessandria, Italy

[17] ARNAS G Brotzu, Osped A Businco, Hematol & Stem Cell Transplantat Unit, Cagliari, Italy

[18] Univ Ferrara, Dept Med Sci, Hematol Sect, Azienda Osped Univ,Arcispedale S Anna, Ferrara, Italy

[19] Univ Perugia, Inst Hematol, Perugia, Italy

[20] Univ Perugia, Ctr Hematooncol Res, Perugia, Italy

[21] Santa Maria Misericordia Hosp, Perugia, Italy

[22] Fdn Policlin Univ Agostino Gemelli IRCSS, Hematol Inst, Rome, Italy

[23] Univ Hull, Ctr Biomed, Kingston Upon Hull, England

[24] Univ Padua, Dept Med, Hematol & Clin Immunol Unit, Via Giustiniani 2, I-35128 Padua, Italy

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 09期

关键词：

D O I：

10.1002/ajh.27009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E237 / E240

页数：4

共 13 条

[1] Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study
Al-Sawaf, Othman
Zhang, Can
Lu, Tong
Liao, Michael Z.
Panchal, Anesh
Robrecht, Sandra
Ching, Travers
Tandon, Maneesh
Fink, Anna-Maria
Tausch, Eugen
Schneider, Christof
Ritgen, Matthias
Boettcher, Sebastian
Kreuzer, Karl-Anton
Chyla, Brenda
Miles, Dale
Wendtner, Clemens-Martin
Eichhorst, Barbara
Stilgenbauer, Stephan
Jiang, Yanwen
Hallek, Michael
Fischer, Kirsten
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4049 - +
[2] Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Baliakas, Panagiotis
Jeromin, Sabine
Iskas, Michalis
Puiggros, Anna
Plevova, Karla
Nguyen-Khac, Florence
Davis, Zadie
Rigolin, Gian Matteo
Visentin, Andrea
Xochelli, Aliki
Delgado, Julio
Baran-Marszak, Fanny
Stalika, Evangelia
Abrisqueta, Pau
Durechova, Kristina
Papaioannou, George
Eclache, Virginie
Dimou, Maria
Iliakis, Theodoros
Collado, Rosa
Doubek, Michael
Jose Calasanz, M.
Ruiz-Xiville, Neus
Moreno, Carolina
Jarosova, Marie
Leeksma, Alexander C.
Panayiotidis, Panayiotis
Podgornik, Helena
Cymbalista, Florence
Anagnostopoulos, Achilles
Trentin, Livio
Stavroyianni, Niki
Davi, Fred
Ghia, Paolo
Kater, Arnon P.
Cuneo, Antonio
Pospisilova, Sarka
Espinet, Blanca
Athanasiadou, Anastasia
Oscier, David
Haferlach, Claudia
Stamatopoulos, Kostas
[J]. BLOOD, 2019, 133 (11) : 1205 - 1216
[3] Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
Blombery, Piers
Thompson, Ella R.
Tamia Nguyen
Birkinshaw, Richard W.
Gong, Jia-Nan
Chen, Xiangting
McBean, Michelle
Thijssen, Rachel
Conway, Thomas
Anderson, Mary Ann
Seymour, John F.
Westerman, David A.
Czabotar, Peter E.
Huang, David C. S.
Roberts, Andrew W.
[J]. BLOOD, 2020, 135 (10) : 773 - +
[4] Treatment of Chronic Lymphocytic Leukemia
Burger, Jan A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) : 460 - 473
[5] ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
Malcikova, J.
Tausch, E.
Rossi, D.
Sutton, L. A.
Soussi, T.
Zenz, T.
Kater, A. P.
Niemann, C. U.
Gonzalez, D.
Davi, F.
Gonzalez Diaz, M.
Moreno, C.
Gaidano, G.
Stamatopoulos, K.
Rosenquist, R.
Stilgenbauer, S.
Ghia, P.
Pospisilova, S.
[J]. LEUKEMIA, 2018, 32 (05) : 1070 - 1080
[6] TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases
Morabito, Fortunato
Del Poeta, Giovanni
Mauro, Francesca Romana
Reda, Gianluigi
Sportoletti, Paolo
Laurenti, Luca
Coscia, Marta
Herishanu, Yair
Bossio, Sabrina
Varettoni, Marzia
Murru, Roberta
Chiarenza, Annalisa
Visentin, Andrea
Condoluci, Adalgisa
Moia, Riccardo
Pietrasanta, Daniela
Loseto, Giacomo
Consoli, Ugo
Scortechini, Ilaria
Recchia, Anna Grazia
Rossi, Francesca Maria
Zucchetto, Antonella
Al-Janazreh, Hamdi
Martino, Enrica Antonia
Vigna, Ernesto
Tripepi, Giovanni
D'Arrigo, Graziella
Galimberti, Sara
Rago, Angela
Angeletti, Ilaria
Biagi, Annalisa
Del Giudice, Ilaria
Bomben, Riccardo
Neri, Antonino
Fronza, Gilberto
Cutrona, Giovanna
Jaksic, Ozren
Olivieri, Jacopo
Rossi, Davide
Di Raimondo, Francesco
Cuneo, Antonio
Gaidano, Gianluca
Polliack, Aaron
Trentin, Livio
Foa, Robin
Ferrarini, Manlio
Gattei, Valter
Gentile, Massimo
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (08) : E306 - E310
[7] Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study
Rigolin, Gian Matteo
Del Giudice, Ilaria
Bardi, Antonella
Melandri, Aurora
Garcia-Jacobo, Rocio Edith
Cura, Francesca
Raponi, Sara
Ilari, Caterina
Cafforio, Luciana
Piciocchi, Alfonso
Arena, Valentina
Reda, Gianluigi
Albano, Francesco
Molica, Stefano
Sportoletti, Paolo
Trentin, Livio
Marchetti, Monia
Nanni, Mauro
Peragine, Nadia
Mariglia, Paola
Vignetti, Marco
Guarini, Anna
Mauro, Francesca Romana
Foa, Robin
Cuneo, Antonio
[J]. BLOOD, 2021, 138 (25) : 2727 - 2730
[8] Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
Seymour, John F.
Kipps, Thomas J.
Eichhorst, Barbara F.
D'Rozario, James
Owen, Carolyn J.
Assouline, Sarit
Lamanna, Nicole
Robak, Tadeusz
de la Serna, Javier
Jaeger, Ulrich
Cartron, Guillaume
Montillo, Marco
Mellink, Clemens
Chyla, Brenda
Panchal, Anesh
Lu, Tong
Wu, Jenny Q.
Jiang, Yanwen
Lefebure, Marcus
Boyer, Michelle
Kater, Arnon P.
[J]. BLOOD, 2022, 140 (08) : 839 - 850
[9] Ibrutinib induces durable remissions in treatment-naive patients with CLL and 17p deletion and/or TP53 mutations
Sivina, Mariela
Kim, Ekaterina
Wierda, William G.
Ferrajoli, Alessandra
Jain, Nitin
Thompson, Philip
Kantarjian, Hagop
Keating, Michael
Burger, Jan A.
[J]. BLOOD, 2021, 138 (24) : 2589 - 2592
[10] Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial
Stilgenbauer, Stephan
Eichhorst, Barbara
Schetelig, Johannes
Hillmen, Peter
Seymour, John F.
Coutre, Steven
Jurczak, Wojciech
Mulligan, Stephen P.
Schuh, Anna
Assouline, Sarit
Wendtner, Clemens-Martin
Roberts, Andrew W.
Davids, Matthew S.
Bloehdorn, Johannes
Munir, Talha
Boettcher, Sebastian
Zhou, Lang
Salem, Ahmed Hamed
Desai, Monali
Chyla, Brenda
Arzt, Jennifer
Kim, Su Young
Verdugo, Maria
Gordon, Gary
Hallek, Michael
Wierda, William G.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1973 - +

← 1 2 →